<https://www.drugtargetreview.com/news/772/amgen-announces-positive-top-line-results-phase-3-tesla-trial-evolocumab-patients-homozygous-familial-hypercholesterolemia/#primaryimage>
<http://schema.org/url>
<https://www.drugtargetreview.com/news/772/amgen-announces-positive-top-line-results-phase-3-tesla-trial-evolocumab-patients-homozygous-familial-hypercholesterolemia/>